Trial intelligence / Profile preview

Misoprostol versus haemostatic tourniquet for reducing blood loss during abdominal myomectomy

PACTR201802003039106Completed

Sponsor
University of Ilorin Teaching Hospital
Start
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of misoprostol in Fibromyoma (LM) (2 arms), sponsored by University of Ilorin Teaching Hospital. Primary endpoints: Intra-operative blood loss and Need for intra-operative blood transfusion. Started Jun 2016; status: completed.

02

Drugs

misoprostol
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on PACTR201802003039106.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201802003039106.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call